$IOVA 8-K SEC Filings

Filed On	Filing
05 Oct 2026	8-K: Other Events 1 © 2026, Iovance Biotherapeutics, Inc. © 2026, Iovance Biotherapeutics, Inc. Corporate Overview October 2026 1
29 Sep 2026	8-K: Other Events New Guidance Represents an Increase of $55 Million at the Midpoint from the Prior Range of $350 to $370 Million
06 Aug 2026	8-K: Other Events
06 Aug 2026	8-K: Results of Operations and Financial Condition
02 Jul 2026	8-K: Other Events
10 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders; Other Events
07 May 2026	8-K: Results of Operations and Financial Condition
20 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
24 Feb 2026	8-K: Results of Operations and Financial Condition; Other Events
09 Jan 2026	8-K: Other Events
06 Nov 2025	8-K: Results of Operations and Financial Condition
29 Aug 2025	8-K: Other Events
22 Aug 2025	8-K: Entry into a Material Definitive Agreement
19 Aug 2025	8-K: Other Events
07 Aug 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
15 Jul 2025	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
03 Jul 2025	8-K: Departure/Election of Directors or Officers; Compensation
13 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation
10 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition

Comments